Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.
Front Endocrinol (Lausanne). 2022 Nov 15;13:1051076. doi: 10.3389/fendo.2022.1051076. eCollection 2022.
Nonalcoholic fatty liver disease (NAFLD) includes a series of hepatic manifestations, starting with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis or even hepatocellular carcinoma (HCC). Its incidence is increasing worldwide. Several factors including metabolic dysfunction, oxidative stress, lipotoxicity contribute to the liver inflammation. Several immune cell-mediated inflammatory processes are involved in NAFLD in which T cells play a crucial part in the progression of the disease. In this review, we focus on the role of different subsets of both conventional and unconventional T cells in pathogenesis of NAFLD. Factors regarding inflammation and potential therapeutic approaches targeting immune cells in NASH are also discussed.
非酒精性脂肪性肝病(NAFLD)包括一系列肝脏表现,从肝脂肪变性开始,可能发展为非酒精性脂肪性肝炎(NASH)、纤维化、肝硬化甚至肝细胞癌(HCC)。其发病率在全球范围内呈上升趋势。多种因素,包括代谢功能障碍、氧化应激、脂毒性,导致肝脏炎症。几种免疫细胞介导的炎症过程参与了 NAFLD 的发生,其中 T 细胞在疾病的进展中起着至关重要的作用。在这篇综述中,我们重点关注了不同亚群的传统和非常规 T 细胞在 NAFLD 发病机制中的作用。还讨论了与炎症相关的因素以及针对 NASH 中免疫细胞的潜在治疗方法。